PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1322305-0	1992	Synergistic induction of interleukin-6 by tumor necrosis factor and lithium chloride in mice: possible role in the triggering and exacerbation of psoriasis by lithium treatment.	Lithium Chloride	68-84	interleukin 6	Mus musculus	25-38	
1322305-0	1992	Synergistic induction of interleukin-6 by tumor necrosis factor and lithium chloride in mice: possible role in the triggering and exacerbation of psoriasis by lithium treatment.	Lithium	68-75	interleukin 6	Mus musculus	25-38	
1322305-5	1992	IL-6 levels in skin extracts of mice treated s.c. with a combination of TNF and LiCl were considerably increased as compared to the levels found in skin extracts from mice treated with TNF or LiCl alone.	Lithium Chloride	80-84	interleukin 6	Mus musculus	0-4	
1322305-5	1992	IL-6 levels in skin extracts of mice treated s.c. with a combination of TNF and LiCl were considerably increased as compared to the levels found in skin extracts from mice treated with TNF or LiCl alone.	Lithium Chloride	192-196	interleukin 6	Mus musculus	0-4	
1322305-5	1992	IL-6 levels in skin extracts of mice treated s.c. with a combination of TNF and LiCl were considerably increased as compared to the levels found in skin extracts from mice treated with TNF or LiCl alone.	Lithium Chloride	192-196	tumor necrosis factor	Mus musculus	72-75	
1322305-8	1992	Injection with IL-1, interferon-gamma, lipopolysaccharide, or phorbol 12-myristate 13-acetate also induced IL-6 in murine skin.	Tetradecanoylphorbol Acetate	62-93	interleukin 6	Mus musculus	107-111	
1322305-11	1992	These results suggest a role for endogenous TNF and IL-6 in the triggering or aggravation of psoriasis in lithium-treated patients.	Lithium	106-113	tumor necrosis factor	Homo sapiens	44-47	
1322305-11	1992	These results suggest a role for endogenous TNF and IL-6 in the triggering or aggravation of psoriasis in lithium-treated patients.	Lithium	106-113	interleukin 6	Homo sapiens	52-56